Gene · 4880
Papers1,757
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,757
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Consensus statement on the management of Achondroplasia in the Middle East. | Front Endocrinol (Lausanne) | 2026 | 42823987 | PubTator, text mining | PubMed |
| The relationship between maternal c-type natriuretic peptide levels and fetal growth restriction. | Ir J Med Sci | 2026 | 42782584 | PubTator, text mining | PubMed |
| A Phase 3 Trial of Vosoritide in Children with Hypochondroplasia. | NEJM Evid | 2026 | 42713641 | PubTator, text mining | PubMed |
| Slipped Capital Femoral Epiphysis during Vosoritide Therapy for Short Stature: A Case Series. | Horm Res Paediatr | 2026 | 42678892 | PubTator, text mining | PubMed |
| Real-World Evidence on the Effectiveness and Safety of Vosoritide in Latin American Patients With Achondroplasia (EVOLAC). | Am J Med Genet A | 2026 | 42675811 | PubTator, text mining | PubMed |
| The First Successful Capacitation In Vitro Maturation of Oocyte in Indonesia: A Promising Strategy to Enhance IVF Accessibility for Infertile Couples. | J Reprod Infertil | 2026 | 42632963 | PubTator, text mining | PubMed |
| Tetrameric neutralization and orthogonal catalytic hairpin assembly for direct differential detection of microRNA. | Anal Chim Acta | 2026 | 42508916 | PubTator, text mining | PubMed |
| Beyond the pump: integrating the heart's endocrine function into early medical education. | Med Educ Online | 2026 | 42455767 | PubTator, text mining | PubMed |
| E2 ubiquitin-conjugating enzyme UBE2T in mural granulosa cells regulates ovine oocyte maturation via the mTOR-CNP signaling pathway. | Theriogenology | 2026 | 42419071 | PubTator, text mining | PubMed |
| Spatial and Molecular Parameters of Pre-OPU Ovarian Follicles and Their Association with Embryo Developmental Competence in Assisted Reproductive Technology. | Int J Mol Sci | 2026 | 42353000 | PubTator, text mining | PubMed |
| Achondroplasia management in the era of targeted therapies: a meta-analysis of C-type natriuretic peptide analogs. | J Endocr Soc | 2026 | 42306228 | PubTator, text mining | PubMed |
| Rapid responses of catecholamines, natriuretic peptides and inflammatory markers to acute type B aortic dissection (NeuroendOcrine horMone release in acute type b Aortic Dissection [NOMAD] Study). | JVS Vasc Sci | 2026 | 42291128 | PubTator, text mining | PubMed |
| Real-world growth outcomes of vosoritide in children with achondroplasia: a single-center cohort study. | J Endocr Soc | 2026 | 42238253 | PubTator, text mining | PubMed |
| Navepegritide: First Approval. | Drugs | 2026 | 42234372 | PubTator, text mining | PubMed |
| Exosomal CNP and CNP-Related microRNAs: An Open Window into Brugada Syndrome? | Biomedicines | 2026 | 42193419 | PubTator, text mining | PubMed |
| C-Type Natriuretic Peptide and Cardiovascular-Renal Protection in Sepsis. | Hypertension | 2026 | 42160495 | PubTator, text mining | PubMed |
| Navepegritide combined with lonapegsomatropin for the treatment of children with achondroplasia: 52-week results from the phase 2 COACH trial. | Eur J Endocrinol | 2026 | 42144862 | PubTator, text mining | PubMed |
| Brain and C-type natriuretic peptide are expressed by the human placenta and are not altered with preeclampsia, fetal growth restriction, or placental hypoxia. | Placenta | 2026 | 42139878 | PubTator, text mining | PubMed |
| C-Type Natriuretic Peptide Derivatives: Orthopaedic Implications in Achondroplasia. | J Pediatr Soc North Am | 2026 | 42028063 | PubTator, text mining | PubMed |
| A phase II basket trial of vosoritide in children with RASopathies, ACAN, and NPR2 deficiency. | J Clin Endocrinol Metab | 2026 | 41967490 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4880/papers